Company profile for Amneal Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) is an integrated specialty pharmaceutical company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets. Together, we’re rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines...
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) is an integrated specialty pharmaceutical company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets. Together, we’re rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Today, Amneal is much more than generics. A series of strategic investments over the years has bolstered our world-class scientific rigor, production capabilities and commercial infrastructure.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
400 Crossing Boulevard, 3rd Floor Bridgewater, New Jersey 08807
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/05/3200657/0/en/Amneal-Announces-Positive-Interim-Phase-4-ELEVATE-PD-Results-With-CREXONT-for-Parkinson-s-Disease.html

GLOBENEWSWIRE
05 Dec 2025

https://www.globenewswire.com/news-release/2025/12/02/3197859/0/en/Amneal-Receives-U-S-FDA-Approval-for-Albuterol-Sulfate-Inhalation-Aerosol.html

GLOBENEWSWIRE
02 Dec 2025

https://www.globenewswire.com/news-release/2025/12/02/3197818/0/en/Amneal-to-Participate-in-Upcoming-Investor-Conferences.html

GLOBENEWSWIRE
02 Dec 2025

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211600

FDA
01 Dec 2025

https://www.globenewswire.com/news-release/2025/12/01/3197418/0/en/Amneal-Announces-U-S-FDA-Approval-of-Cyclosporine-Ophthalmic-Emulsion-0-05.html

GLOBENEWSWIRE
01 Dec 2025

https://www.globenewswire.com/news-release/2025/11/13/3187799/0/en/Amneal-Receives-U-S-FDA-Approval-for-Iohexol-Injection.html

GLOBENEWSWIRE
13 Nov 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Amneal Pharmaceuticals and get a quotation

Amneal Pharmaceuticals is a supplier offers 6 products (APIs, Excipients or Intermediates).

Find a price of Bacitracin Zinc bulk offered by Amneal Pharmaceuticals

Find a price of Calcium Amphomycin bulk offered by Amneal Pharmaceuticals

Find a price of Iopamidol bulk offered by Amneal Pharmaceuticals

Find a price of Metformin bulk offered by Amneal Pharmaceuticals

Find a price of Pilocarpine Hydrochloride bulk offered by Amneal Pharmaceuticals

Find a price of Rifaximin bulk offered by Amneal Pharmaceuticals

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty